We have addressed the capacity of HIV-1 infection to alter the growth of primary CD4+ T cells, but at the clonal level. Single T cells were expanded in the presence of PHA, IL-2, and small numbers of accessory dendritic cells. We report two new findings. First, T cells from seropositive individuals, even those with AIDS and markedly reduced CD4+ counts, exhibit a normal cloning efficiency, and proliferative capacity. This result is in contrast to two prior reports of a low cloning efficiency in CD4+ T cells from HIV-1-infected patients. Second, when we added high doses of exogenous HIV-1 to T cell clones from control subjects, we observed infection but not cytotoxicity or loss of CD4+ cells, following addition of virus stocks at days 0, 3, and/or 7 of clonal growth. The same HIV-1 isolates markedly reduced CD4+ T cells in bulk mononuclear cultures. When tested at day 11, HIV-1 mRNA was expressed in some cells of exogenously infected clones by in situ hybridization; when tested at day 18, several clones could transactivate a TAT-sensitive cell line. These findings suggest that the loss of CD4+ T cells in infected individuals is not the inevitable result of the activation of latent infection, or spread of a productive infection, during clonal growth.
Introduction
The immune deficiency associated with HIV-l infection is characterized by a progressive loss ofCD4+ T lymphocytes (1) . The lethal opportunistic infections of the disease are to a large extent ascribed to malfunction and depletion of the CD4+ subset, for which HIV-1 virus has a well-established tropism (2) (3) (4) . However, the frequency of CD4+ cells that are productively infected with HIV-l is much < 1% (5) . To explain the marked depletion of CD4+ lymphocytes, it is possible that many T cells carry latent virus, which becomes activated upon antigen stimulation of lymphocytes leading to cell lysis (1, 6) . Indeed, it has been reported that T cells from HIV-1 infected patients cannot be cloned efficiently in vitro (7, 8) . One explanation would be an early cell lysis of growing T cell clones by activation of latent virus. Another proposed mechanism for the loss of CD4+ cells is that a small number of productively infected cells may kill normal T cells after syncytium formation (9) . We have addressed these possible etiologies for the loss of CD4' T cells by using a recently described cloning technique. The method allows early visual detection of developing CD4' T cell clones in response to a mitogenic stimulus (10) . Surprisingly, we find little evidence for a cytopathic infection in CD4' T cells, from endogenous or exogenous HIV-1, when the T cells are grown as clones in the presence of dendritic cells from seronegative individuals. These findings indicate that the proliferative potential of most T cells from HIV-I infected individuals can be substantial.
Methods
Patients. 50 ml heparinized venous blood was obtained on three occasions by venipuncture of 14 HIV-I seropositive male homosexuals with no record of intravenous drug abuse. All patients had below normal CD4+/CD8' ratios, and most had low absolute CD4' T cell counts (see Table I ). All patients were on a previous occasion skin tested for delayed type hypersensitivity responses to a group of antigens: 0. 1 Endogenous HIV-I production from CD4 positive patient T cells. The CD4' T cells from the erythrocyte rosette fraction (1 X 106 cells/ ml in 6 ml) were cocultured with PHA stimulated lymphoblasts (0.5 X 106/ml) in 25 cm2 tissue culture flasks (Costar, Cambridge, MA) and were supplemented with IL-2 (600 U/ml; New England Nuclear Research Products, Boston, MA). Culture supernatants were collected over 3-5-d intervals, concentrated with polyethylene glycol 8000 and analyzed for virus production by p24 antigen ELISA (New England Nuclear). Productive infection in T cell clones was measured similarly by p24 ELISA from 100 Ml of the clone supernatants.
Infection ofbulk cultures and T cells clones with exogenous HTL VIIb. For in vitro propagation of virus in bulk cultures of blood mononuclear cells, the system described by McDougal et al. was used (6) . Ficoll-Paque separated mononuclear cells from seronegative donors were stimulated with 20 ug/ml PHA for 3 d at 2 X 106 cells/ml in medium. The PHA-stimulated cells were harvested by centrifugation and resuspended to 2 X 106 cells/ml in medium without PHA but supplemented with 300 U/ml rIL-2. The lymphoblast-rich cell cultures were inoculated with an HIV-I supernatant containing HTLV-IIIb virus (10,000 cpm reverse transcriptase/ml) or with a fresh patient isolate that had been expanded on PHA stimulated T cell blasts. Every 3 d the culture medium was exchanged with rIL-2 supplemented fresh medium, and the cultures were maintained at I to 2 X 106 cells/ml. At each time point, viable cell counts were determined by trypan blue exclusion, and expression of CD3+, CD4+, and CD8+ antigens was measured by flow cytometry. Cytocentrifuged cell preparations for in situ hybridization (below) were also made. For propagation of virus in CD4+ T cell clones, the HTLV-IIIb isolate was in six different experiments added (25 gl) to the cloning wells at days 0, 3, or 7 (1,400, 700, or 70 cpm/well). In two additional experiments a patient HIV-I isolate was added to the cloning wells at day 3 (700 cpm/well). In control plates, 25 ,l of supernatant from an uninfected CEM-4 cell line or from uninfected T cell cultures were used.
In situ hybridization for HIV-J mRNA. For in situ hybridization studies glass slides were coated for 3 h in Denhardt's medium ( 13) at 65°C, dipped briefly in distilled water, transferred to ethanol-acetic acid (3:1 vol/vol) for 20 min and air dried. After making the cytocentrifuge preparations (3 X 104 cells per slide; cytocentrifuge; Shandon Southern Instruments, Inc., Sewickley, PA) the slides were air dried and immediately fixed for 20 min at room temperature in freshly prepared 4% paraformaldehyde in phosphate-buffered saline (PBS) with 5 mM MgCl. The slides were rinsed for 3 min in 3X PBS, twice for I min in I X PBS, and dehydrated in ethanol. After drying the slides were stored at -20°C until use.
The plasmid pBH10, containing a 9-kb insert with the complete cDNA of HTLV-III (14, 15) , was digested with Bam HI and Hind III. The 0.6 kB Hind III fragment, containing a part of the gag gene was isolated and random primer labeled as described (16) (17) . This cell line carries an HIV-l 5' LTR-CAT construct, which is transactivated upon contact with a small number of infected cells (17) . Briefly, the total content (150 ul) of the cloning wells (with or without clones) were transferred at day 18 to cultures with 2.5 X 105 H938 cells in 1 ml growth medium and cultured for 48 h before analysis of CAT enzyme activity. A positive CAT assay reflects transactivation ofthe CAT gene by the TAT product from cells infected with HIV-I (17) .
Statistical analysis. Differences in cloning efficiencies between groups were tested with an analysis of variance (one-way). P < 0.05 were considered significant.
Results
Patient sample. 14 seropositive patients were included in this study (Table I) . Half had symptoms, and two of these had AIDS and Kaposi's sarcoma. Most patients had a decreased absolute number ofCD4' T cells, and the CD4/CD8 ratio was < 1. Only four patients exhibited delayed type hypersensitivity upon skin testing with Candida, Trichophyton, and PPD antigens.
Cloning of T cells from HIV-I-infected patients. In the cloning assay we used dendritic cells from a seronegative donor as accessory cells for the prolonged growth of single T cells from patients or from control subjects. Because only 1,000 dendritic cells were needed to induce a maximal yield of iì Z clones (10) , it was possible to identify the growing clones as early as day 5 of culture. Typical clones from two patients and one control at day 7 are shown in Fig. 1 . At day 14, the clones had increased further in size, so that the cultures contained a cluster ofcells surrounded by a large sheath oflymphoblasts as described (10) . In all cases, the sizes of the patient clones and cell viability (trypan blue) were comparable to the controls.
There was no evidence of syncytium formation (Fig. 1) We also examined the cloning efficiency of single T cells expanded in exogenous rIL-2 rather than bulk T cell conditioned medium (Table III Single CD4' T cells from two patients with low CD4' T cell counts were cloned using as a source of growth factor either bulk leukocyte conditioned medium (which contained > 280 U/ml of INF-y) or rIL-2 with PHA. The efficiency of cloning was measured at days 7, 10, and 14 in 100-120 wells. cultures from patients 2 and 8 with lymphoblasts and IL-2 produced p24 (data not shown).
Normal expression of CD4 antigen on patient clones. Expression of CD4 and CD8 was monitored by two-color flow cytometry in 4 control clones and in 12 clones from patients. PE-anti-CD8 and FITC-anti-CD4 were added directly to the cloning wells at 11 d of growth. 11/12 patient clones were CD4'CD8-, and the level of CD4 was comparable to control clones (Fig. 2) .
Cloning of normal T cells in the presence of exogenous HIV-1. A high dose ofa standard T lymphotropic virus isolate, HTLV-IIIb, was added to single cell cloning wells of control donors at day 0 and/or day 3. The highest doses of virus in terms of RTase units (1, 400 or 700 U/150 gl) in a round-bottomed well with one T cell was roughly comparable to the dose used to establish a productive infection in bulk mononuclear cells (10,000 U/ml). Remarkably, cloning efficiency was not decreased (Table IV) , and there was no evidence of cytotoxicity (trypan blue stain) or syncytium formation (Fig. 1, e andf) . In two other experiments, virus was added at days 0 and 7 with the same results, i.e., no observed cytopathic effects. When the same virus stock was added to bulk blood mononuclear cell cultures, the virus caused the expected loss of CD4' cells that has been reported by others (6, 18) . A second HIV-1 isolate, derived from a patient and propagated in short-term culture with PHA-stimulated human T lymphoblasts, was also added to cloning wells at day 3. In two experiments, the cloning efficiencies at day 14 were again not affected by exogenous HIV-l virus (78 and 84%), even though this isolate also eliminated most CD4 cells from 11 to 14 d PHA-stimulated bulk mononuclear cells. Since exogenous HIV-1 was lytic for bulk mononuclear cells, but not T cells growing as clones with accessory dendritic cells, we examined the clones for productive infection. Because of the high dose of exogenous HIV, p24 assays gave a high background even in wells without clones. Therefore, we evaluated the clones by in situ hybridization with a 3H-cDNA probe for HIV-I gag mRNA. Positive cells were seen in bulk mononuclear cells infected with HIV-1 (Table V) . Of eight clones examined at day 11 of growth, three contained T cells with HIV-l mRNA (Table V) . Fig. 3 shows the clarity ofthe in situ approach on bulk mononuclear cells (Fig. 3a) , CEM T cell cultures (Fig. 3 b) , and a T cell clone (Fig. 3 d) all infected with the same HTLV-IIIb isolate. The grain counts were similar in the clonal and bulk T cell cultures, suggesting that the levels of gag mRNA were similar. At no time did we observe hybridization signals on uninfected cells (Fig. 3 c) .
To detect the presence of an active tat gene product in the exogenously infected clones, we cocultured the clones with the CD4+ H938 cell line tranfected with LTR-CAT. Three of seven clones tested at day 18 induced responses by the CAT assay. Fig. 4 shows transactivation by two clones (lanes 1 and 3) of four shown. In wells without clones, but with exogenous HIV-1, little or no CAT enzyme activity was detected (lanes 6 and 7). Therefore, clonal expansion of T cells occurs in our culture system in the presence of some HIV-l-infected lymphocytes. 
Discussion
The malfunction and loss of CD4' T cells is a critical consequence of HIV-l infection and likely predisposes to lethal opportunistic infections. Our experiments consider some of the possible mechanisms for the loss of CD4' T cells, but in contrast to many prior studies we have emphasized freshly isolated CD41 cells and clonal assays. Although very few blood cells are productively infected with HIV-1 (5), there is evidence that the infection is much more extensive. First, it has been reported that single CD41 T cells from patients can only be cloned with a very low efficiency (7, 8) . This suggests that many T cells are carrying latent virus, which is activated upon clonal expansion, or that single T cells carry a strong inhibitor of cell growth. Second, in studies with cell lines, a few infected cells transmit by syncytium formation the infection to uninfected cells (9) . Our observations, however, provide a very different picture of the growth potential of CD41 T cells even when taken from patients with extensive loss of CD41 T cells.
When single CD4' T cells from HIV-infected individuals were stimulated in culture with PHA, growth factors, and normal accessory dendritic cells, the lymphocytes grew continuously producing large clones with the same efficiency as T cells from controls (Table II) . There was no evidence for production of HIV p24, for a loss of CD4 antigen that can occur upon HIV infection (3, (18) (19) (20) , or for cytotoxicity and syncytium formation. Therefore, the idea that many T cells are carrying latent HIV, which can be activated upon clonal expansion, does not seem to be the case even in a group of patients with low CD4 counts and frank ARC/AIDS (Table I) Other studies of the cloning capacity of T lymphocytes from HIV infected patients have reported a decreased cloning efficiency with different experimental protocols. In one study, single T cells were cloned in the presence of rIL-2, PHA and bulk mononuclear cells as accessory cells. The cloning efficiency was decreased (range 15-36%) for both CD41 and CD8' subsets (7) . A second study (8) found more than a five fold decrease in the cloning efficiency, again ofboth CD8' and CD4' cells, using a limiting dilution approach. Both studies used a high number of bulk mononuclear cells as accessory cells, and not dendritic cells. It is conceivable that the use of enriched dendritic cells improves clonal growth. In both prior reports, the cloning efficiency of patient CD8' cells was also found decreased. Some of the patients in these studies differed from the patients in our study by having CD4' T cell counts < 100 per mm3. However, the median cloning efficiency of CD4' T cells from these patients was not different from that of patients with CD4' T cell counts > 100/mm3. It is possible that the coculture with dendritic cells provides a protective environment that may not be present when bulk mononuclear cells are used as accessory cells. This possibility is currently under investigation. Of some interest as well will be to test if dendritic cells from patients will support the cloning ofnormal or patient T cells. Such experiments, however, will require improved methods for enriching dendritic cells from small volumes of patient blood.
It was clear that exogenous HIV-1 dramatically reduced CD4' cell counts when bulk mononuclear cells were being stimulated with PHA (Table V) as was the experience ofothers (1, 4, 6, 21 ). Yet we did not observe this to be the case in our primary clones using a standard HTLVIIIb virus stock, and we had similar results with a fresh patient virus isolate. Exogenous virus (HTLVIIIb) clearly infected some ofthe cells in the T cell clones, and the levels of gag mRNA by in situ hybridization were comparable to bulk mononuclear cells (Figs. 3 and 4) . Nonetheless the clones remained robust, and syncytia were never apparent. It is possible that the few cells that became infected in our cloning cultures died rather than propagated the infection. Alternatively, a persistent but noncytopathic infection could have been established as has been noted in one study ofbulk cultures (18) . We will examine these possibilities in the future using the polymerase chain reaction to detect HIV-l DNA.
